Top Health-care stocks:
Health-care shares were mainly lower in pre-market trade on Thursday.
In health-care stocks news, pharmaceutical company Merck & Company ( MRK ) said the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for single-dose EMEND (fosaprepitant dimeglumine) to prevent nausea and vomiting in patients receiving chemotherapy.
Shares in the company were 0.8% lower at $49.64 pre-bell. The company has traded between $45.69 and $61.70 over the past 52 weeks.
And Seattle Genetics ( SGEN ) said it will receive a one-time $20 million milestone payment under its ADCETRIS collaboration with Takeda Pharmaceutical Company.
Shares in the company unchanged at $32.31 pre-bell. The company has traded between $29.31 and $52.33 over the past 52 weeks.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.